Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial
Titel:
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial
Auteur:
Paton, Nicholas I Musaazi, Joseph Kityo, Cissy Walimbwa, Stephen Hoppe, Anne Balyegisawa, Apolo Asienzo, Jesca Kaimal, Arvind Mirembe, Grace Lugemwa, Abbas Ategeka, Gilbert Borok, Margaret Mugerwa, Henry Siika, Abraham Odongpiny, Eva Laker A Castelnuovo, Barbara Kiragga, Agnes Kambugu, Andrew
Verschenen in:
The Lancet. HIV
Paginering:
Jaargang 9 () nr. 6 pagina's e381-e393
Jaar:
2022
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license